# Statin and Dual Antiplatelet Therapy to Prevent Early Neurological Deterioration in Branch Atheromatous Disease

> **NCT04824911** · PHASE2 · COMPLETED · sponsor: **Chang Gung Memorial Hospital** · enrollment: 376 (actual)

## Conditions studied

- Acute Stroke
- Dual Antiplatelet Therapy
- Statin

## Interventions

- **DRUG:** Clopidogrel
- **DRUG:** Aspirin
- **DRUG:** Atorvastatin
- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT04824911
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-23
- **Primary completion:** 2025-02-28
- **Final completion:** 2025-02-28
- **Target enrollment:** 376 (ACTUAL)
- **Last updated:** 2025-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04824911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04824911, "Statin and Dual Antiplatelet Therapy to Prevent Early Neurological Deterioration in Branch Atheromatous Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04824911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*